Difference between revisions of "AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Ctte"
Jump to navigation
Jump to search
OKripfgans (talk | contribs) |
m |
||
| (35 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
| + | {{TOCright}} | ||
| + | :Co-chairs: J. Brian Fowlkes, PhD; James Jago, PhD; Oliver D. Kripfgans, PhD | ||
| + | :AIUM Staff Support: Therese Cooper, BS, RDMS (AIUM) | ||
| + | *[https://docs.google.com/spreadsheets/d/1XiqzHSRHRJt8WyU-zNqcf03KsJ27S9me/edit#gid=2134575213|VBF Roster] | ||
| + | |||
| + | |||
==Project Snapshot== | ==Project Snapshot== | ||
| − | + | Develop a quantitative imaging profile for Volume Blood Flow imaging. | |
| − | + | This effort is supported by AIUM, using the QIBA Process for Profile development. | |
| − | |||
| − | ==Meetings | + | ==Meetings== |
*[[Volume Blood Flow Call Summaries]] | *[[Volume Blood Flow Call Summaries]] | ||
| − | + | ==Profile Development== | |
| − | == | + | *[[Media:QIBA-Phantom-Specifications.pdf|2016-10-20 QIBA Phantom Specifications]] |
| + | |||
| + | ==Historical Background - Formation of the Group== | ||
| + | |||
| + | ===AIUM 2015=== | ||
| + | *A joint QIBA / AIUM Ultrasound Meeting was held at the recent AIUM 2015 Annual Convention on Tuesday, March 24th between 10:30 - 12:45 pm ET to discuss selection of a new biomarker effort for Ultrasound. | ||
| + | *The group discussed proposals for selection of a quantitative imaging technology and clinical target to recommend for a joint QIBA/AIUM effort to develop a quantitative ultrasound imaging biomarker profile. | ||
| + | *Below are meeting minutes and supporting presentations from this meeting for reference: | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | '''Meeting Minutes:''' | |
| + | *[[Media:03 24 2015 QIBA-AIUM Joint Biomarker Mtg Minutes.pdf|03 24 2015 QIBA - AIUM Joint Biomarker Meeting Minutes]] | ||
| + | '''Presentations and Reports from March 24, 2015 session:''' | ||
| + | *[[Media:Spatial Volume Measurements.pdf|Spatial Volume Measurements - Liver Tumor Volume Estimation - presented by Dr. Garra (Washington DC VA Medical Center / FDA)]] | ||
| + | *[[Media:Summary of DCE-US.pdf|Summary of DCE-US - presented by Dr. Fowlkes (University of Michigan)]] | ||
| + | *[[Media:Functional and Structural Imaging with Microbubble Contrast Agents.pdf|Functional and Structural Imaging with Microbubble Contrast Agents - presented by Dr. Eckersley (King's College, London)]] | ||
| + | *[[Media:Cancer Detection in Human Lymph Nodes.pdf|QUS-Based Cancer Detection in Human Lymph Nodes - presented by Dr. Mamou (Riverside Research Institute, NY)]] | ||
| + | *[[Media:Carotid Volume Flow.pdf|Carotid Volume Flow - presented by Dr. J. Rubin (University of Michigan)]] | ||
| + | *[[Media:SHAPE as a Screening Tool for Portal Hypertension.pdf|SHAPE as a Screening Tool for Portal Hypertension - presented by Dr. Forsberg (Thomas Jefferson University)]] | ||
==Reference Materials== | ==Reference Materials== | ||
| − | Original Proposal to the QIBA Steering Committee | + | |
| − | [[ | + | *:[[Media:VolFlowUS_QIBA_BiomarkerProposal.pdf|'''Original Proposal to the QIBA Steering Committee''']] |
| + | |||
| + | *:[[Media:GeneralVendorAnnouncement.pdf|'''General Vendor Announcement''']] | ||
| + | |||
| + | *:[[Media:TransplantRAS-JG2009.pdf|'''Kidney transplant paper showing geometries (Gao 2009)''']] | ||
| + | |||
| + | *:[[Media:Hoyt_JUM_2009.pdf|'''Accuracy of Volumetric Flow Rate Measurements - An In Vitro Study Using Modern Ultrasound Scanners (Hoyt 2009)''']] | ||
| + | |||
| + | *:[[Media:QIBA_Patent_Disclosure_Policy-27March2015.pdf|'''QIBA Patent Disclosure Policy (27 March 2015)''']] | ||
| + | |||
| + | *:[[Media:2016_RSNA-QIBA_Poster.pdf|'''QIBA RSNA Poster (2016)''']] | ||
| + | |||
| + | *:[[Media:US VBF Poster2017.pdf|'''QIBA RSNA Poster (2017)''']] | ||
| + | |||
| + | *:[[Media:2020 Profile Overview.pdf|'''Profile Overview (2020)''']] | ||
| + | |||
| + | ==QIBA Funded Projects== | ||
| + | |||
| + | ====Round 6==== | ||
| + | *[[Media:Examination of Flow Phantom as Reference Standard for Validation of Ultrasound VBF.pdf | Project (W) Examination of Flow Phantom as Reference Standard for Validation of Ultrasound Volume Blood Flow Measurement (University of Michigan)]] | ||
Revision as of 16:24, 30 July 2020
- Co-chairs: J. Brian Fowlkes, PhD; James Jago, PhD; Oliver D. Kripfgans, PhD
- AIUM Staff Support: Therese Cooper, BS, RDMS (AIUM)
Project Snapshot
Develop a quantitative imaging profile for Volume Blood Flow imaging.
This effort is supported by AIUM, using the QIBA Process for Profile development.
Meetings
Profile Development
Historical Background - Formation of the Group
AIUM 2015
- A joint QIBA / AIUM Ultrasound Meeting was held at the recent AIUM 2015 Annual Convention on Tuesday, March 24th between 10:30 - 12:45 pm ET to discuss selection of a new biomarker effort for Ultrasound.
- The group discussed proposals for selection of a quantitative imaging technology and clinical target to recommend for a joint QIBA/AIUM effort to develop a quantitative ultrasound imaging biomarker profile.
- Below are meeting minutes and supporting presentations from this meeting for reference:
Meeting Minutes:
Presentations and Reports from March 24, 2015 session:
- Spatial Volume Measurements - Liver Tumor Volume Estimation - presented by Dr. Garra (Washington DC VA Medical Center / FDA)
- Summary of DCE-US - presented by Dr. Fowlkes (University of Michigan)
- Functional and Structural Imaging with Microbubble Contrast Agents - presented by Dr. Eckersley (King's College, London)
- QUS-Based Cancer Detection in Human Lymph Nodes - presented by Dr. Mamou (Riverside Research Institute, NY)
- Carotid Volume Flow - presented by Dr. J. Rubin (University of Michigan)
- SHAPE as a Screening Tool for Portal Hypertension - presented by Dr. Forsberg (Thomas Jefferson University)